A

Avexxin AS

3 employees

Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology

Pharmaceutical

Date founded

2005

Funding rounds raised

A

Avexxin AS raised undisclosed on January 10, 2011

Investors: Sarsia, Leiv Eiriksson Nyskaping AS and Sarsia

FAQ